This is a combined synopsis/solicitation for commercial supplies/services prepared in accordance with the format in FAR Subpart 12.6 and FAR Part 13 Simplified Acquisition Procedures, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a written solicitation will not be issued. The solicitation number is W81K00-21-Q-0268 and is issued as a Request for Quote (RFQ). This solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2021-05 and Defense Federal Acquisition Regulation Supplement Publication Notice (DPN) 20210224.

This solicitation is for Naloxone Oral Syringe Compound for the Department Of Pharmacy, Brooke Army Medical Center, JBSA Fort Sam Houston, TX. The estimated performance date is 1 October 2021 - 30 September 2022 plus (1) one option year. The associated North American Industrial Classification System (NAICS) code for this procurement is 325412, with a size standard of 1250. This procurement is being conducted as a small business set-aside.

Offers are due by 13 September 2021, at 10:00 AM, Central Standard Time. The point of contact is Gerry Coleman at [email protected]. Offers shall be submitted via e-mail. Questions shall be submitted via e-mail not later than 9 September 2021. No questions will be entertained after this date.